PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-08-16

Date Title Company
16-Aug-2024 Dr. Amir Bajoghli and Skin & Laser Dermatology Center Introduce Sculptra Aesthetic for Advanced Facial Rejuvenation AccessWire
16-Aug-2024 Dr. Paul Vitenas Named on Texas Super Doctors(R) for 2024 in Texas Monthly's 21st Year Celebration AccessWire
16-Aug-2024 Safe Seated Mammography Using Enable Me's VELA Mammography Chair Can Improve Image Clarity this World Breast Cancer Research Day Aug. 18 AccessWire
16-Aug-2024 SYNBIOTIC Annual General Meeting on 20.09.2024: Increasing sales drive growth SYNBIOTIC SE
16-Aug-2024 New gastric & gastro-oesophageal junction cancer treatment VYLOY™ ▼ (zolbetuximab): the first claudin 18.2 biomarker targeted therapy licensed in Great Britain Astellas Pharma Ltd
16-Aug-2024 osteolabs Publishes First Real-World Evidence Data from Close to 3,000 OsteoTest Patient Samples osteolabs
16-Aug-2024 Peptide-ExplorerLT launched by Vapourtec ...aimed at chemists looking to explore and optimise linear peptide synthesis Vapourtec
16-Aug-2024 CV6 Therapeutics Announces Initiation of Patient Dosing in Phase 1a Clinical Trial Evaluating the Investigational First-In-Class, Specific dUTPase Inhibitor CV6-168 CV6 Therapeutics
16-Aug-2024 A-Level students urged to consider pharmaceutical careers Association of the British Pharmaceutical Industry (ABPI)
16-Aug-2024 New gastric & gastro-oesophageal junction cancer treatment VYLOY™ ▼ (zolbetuximab): the first claudin 18.2 biomarker targeted therapy licensed in Great Britain Astellas Pharma Ltd
16-Aug-2024 Compounding Pharmacies Market on the Rise: Estimated Value to Hit USD 20.2 Billion by 2032 Global Market Insights, Inc.
16-Aug-2024 Original-Research: APONTIS PHARMA AG (von First Berlin Equity Research GmbH) APONTIS PHARMA AG